日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intravenous Nanoemulsions Loaded with Phospholipid Complex of a Novel Pyrazoloquinolinone Ligand for Enhanced Brain Delivery

用于增强脑递送的载有新型吡唑喹啉酮配体磷脂复合物的静脉纳米乳剂

Stanković, Tijana; Ilić, Tanja; Divović Matović, Branka; Petkovic, Milos; Dobričić, Vladimir; Jančić, Ivan; Bufan, Biljana; Jezdić, Kristina; Đoković, Jelena; Pantelić, Ivana; Randjelović, Danijela; Sharmin, Dishary; Cook, James M; Savić, Miroslav M; Savić, Snežana

Pharmacological manipulation of liver fibrosis progression using novel HDAC6 inhibitors.

利用新型 HDAC6 抑制剂进行肝纤维化进展的药理学调控

Borrello Maria Teresa, Ruzic Dusan, Paish Hannah, Graham Eleanor, Collins Amy L, Scott Rebecca, Higginbotham Sam, Radovic Branko, Nelson Glyn, Bulmer David, Borthwick Lee A, Robinson Stuart M, French Jeremy, Moir John, White Steve A, Wilson Colin, Pandanaboyana Sanjay, Hammond John, Thakkar Rohan, Alrawashdeh Wasfi, Figueiredo Rodrigo, Petkovic Milos, Nikolic Katarina, Oakley Fiona, Mann Derek A, Mann Jelena

Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents.

开创性的首创 HDAC-ROCK 抑制剂作为潜在的多靶点抗癌药物

Beljkas Milan, Ruzic Dusan, Djuric Ana, Vuletic Ana, Tchiehe Guilaine Nchugoua, Jallet Corinne, Cadet-Daniel Véronique, Arimondo Paola B, Santibanez Juan F, Srdic-Rajic Tatjana, Nikolic Katarina, Oljacic Slavica, Petkovic Milos

Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design

通过三维定量构效关系(3D-QSAR)和分子对接研究开发新型ROCK抑制剂:多靶点药物设计的框架

Beljkas, Milan; Petkovic, Milos; Vuletic, Ana; Djuric, Ana; Santibanez, Juan Francisco; Srdic-Rajic, Tatjana; Nikolic, Katarina; Oljacic, Slavica

Anti-biofilm Properties of Bacterial Di-Rhamnolipids and Their Semi-Synthetic Amide Derivatives

细菌二鼠李糖脂及其半合成酰胺衍生物的抗生物膜特性

Aleksic, Ivana; Petkovic, Milos; Jovanovic, Milos; Milivojevic, Dusan; Vasiljevic, Branka; Nikodinovic-Runic, Jasmina; Senerovic, Lidija